Responses
CASE REPORT
Autologous human cardiac stem cells transplantation for the treatment of ischaemic cardiomyopathy: first study of human-induced pluripotent stem (iPS) cell-derived cardiomyocytes transplantation
Compose a Response to This Article
Other responses
No responses have been published for this article.